T1-mapping in myocardial disease : principles and applications / Phillip C. Yang, editor.
Yang, Phillip C., editor.
2018
RC685.M9
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
T1-mapping in myocardial disease : principles and applications / Phillip C. Yang, editor.
ISBN
9783319911106 (electronic book)
3319911104 (electronic book)
9783319911090
3319911090
DOI
https://doi.org/10.1007/978-3-319-91110-6
Published
Cham, Switzerland : Springer, [2018]
Language
English
Description
1 online resource : illustrations
Item Number
10.1007/978-3-319-91110-6 doi
Call Number
RC685.M9
Dewey Decimal Classification
616.124
Summary
This book details the advances in cardiac MRI that have enabled quantitative tissue characterization of the myocardium using myocardial and blood T1 measurements, which have enabled reliable detection of diffuse pathological processes in both the cardiomyocytes and the interstitial cells of the myocardium. Evaluation of the native myocardial and interstitial fibrosis, and measurement of the extracellular volume fraction has allowed an unprecedented opportunity to elucidate the pathology, diagnosis and prognosis of cardiovascular disease. T1-Mapping in Myocardial Disease: Principles and Applications reviews a wide spectrum of significant cardiovascular disease and provides relevant guidance for the clinical implementation of this innovative technique. The specific topics covered include principles of T1-mapping in cardiovascular disease and the role of T1-mapping in hypertensive heart disease and hypertrophic cardiomyopathy, cardiotoxicity from cancer treatment, cardiacfibrosis, left ventricular hypertrophy in aortic stenosis, peri-infarct injury in ischemic cardiomyopathy, and stem cell therapy. This comprehensive coverage of the utility of T1-mapping in cardiovascular diseases will greatly appeal to the entire cardiovascular medicine and imaging communities.
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Online resource; title from PDF title page (viewed September 6, 2018).
Added Author
Yang, Phillip C., editor.
Available in Other Form
T1-mapping in myocardial disease.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Intro; Preface; Contents; Contributors; 1: Fundamentals of Cardiac T1 Mapping; T1; T1 Outside of the Heart; T1 in the Heart; Native T1; Late Gadolinium Enhancement; Extracellular Volume Calculation; T1 Mapping Gold Standard; T1 Mapping in the Heart; Look-Locker Techniques: MOLLI and ShMOLLI; Saturation Recovery Techniques: SASHA; T1 Mapping Limitations; Post-Processing; Validation; Recommendations; References; 2: T1 Mapping in Cardiac Hypertrophy; Introduction; Relationship of T1 and ECV to the Pathophysiology of Hypertrophy; Native T1; Extracellular Volume Fraction (ECV).

Intracellular Life-Time of WaterT1 Mapping in Hypertensive Heart Disease; Animal Studies of T1 Mapping in Hypertensive Heart Disease; T1 mapping in Hypertrophic Cardiomyopathy; T1 Mapping in the Evaluation of Hypertrophy in Aortic Stenosis; Using T1 Mapping to Differentiate between Causes of Hypertrophy; Differentiating Hypertensive Heart Disease from HCM; Differentiating Athletic Hypertrophy from HCM; Differentiation of Hypertensive LVH from Infiltrative Cardiomyopathy; T1 Mapping in Right Ventricular Hypertrophy; References; 3: T1 Mapping in Cardiomyopathy from Cancer Treatment.

Cancer and Cardio-oncologyPathophysiology of Cardiomyopathy from Cancer Treatment; Current Imaging Surveillance of LV Function in Cardio-oncology; Left Ventricular Ejection Fraction; Left Ventricular Strain; T1 Mapping in Cardio-oncology; Myocardial Injury; Myocardial Fibrosis; New Challenges in T1 Mapping in Cardio-oncology; Summary; References; 4: Comparison of T1 Mapping by Cardiac MRI to Non-cardiac MRI Methods to Evaluate Cardiac Fibrosis; Introduction; Cardiac MRI (CMR); Novel CMR Approaches; Nuclear Imaging; Echocardiography; Backscatter; Tissue Doppler Imaging (TDI).

Strain and Strain Rate ImagingSpeckle Tracking Echo; Cardiac Computed Tomography (Multidetector CT); References; 5: T1 Mapping in Aortic Stenosis; Epidemiology; Natural History; Clinical Presentation; Pathobiology of Valvular Disease; Pathobiology of LV Remodeling; Myocardial Fibrosis; Investigations; Electrocardiography; Echocardiography; Cardiac Magnetic Resonance; Late Gadolinium Enhancement; T1 Mapping; Native T1; Post-contrast T1 and the Partition Coefficient; Extracellular Volume Fraction; Absolute Extracellular Volume; Barriers to Widespread Adoption; Potential Uses of T1 Mapping.

Future DirectionsReferences; 6: T1 Mapping in Peri-infarct Injury in Ischemic Cardiomyopathy; Ischemic Cardiomyopathy and T1 Mapping; T1 Mapping Techniques in Ischemic Cardiomyopathy; Gadolinium Enhanced Delayed Enhancement; Role of PIR in Predicting Cardiovascular Outcomes in Ischemic Cardiomyopathy; T1 Mapping Using Gadolinium Enhancement; Limitations to Gadolinium Enhancement; T1 Mapping Sequences for Ischemic Cardiomyopathy; SMART1Map; Combination of Intrinsic T1 Versus Contrast Agent-Enhanced T1 Mapping; Native; Gadolinium (Gd); Manganese (Mn); Summary and Future Directions; References.

Browse Subjects

Show more subjects...

Statistics

from
to
Export